No Data
No Data
GRI Bio Raises $13.9M in Gross Proceeds Since Start of 2024
Express News | GRI Bio Raises $13.9M In Gross Proceeds Since Start Of 2024; Funds Expected To Extend Cash Runway Into Mid-Q1 2025, Supporting Interim Data From Phase 2a Study Of GRI-0621 For Idiopathic Pulmonary Fibrosis (IPF) Treatment
12 Health Care Stocks Moving In Wednesday's Intraday Session
Top Midday Decliners
Dow Falls Over 150 Points; General Motors Tops Q3 Views
Wall Street Set to Open Lower as Investors Await Earnings Report, Harker Speech
No Data
No Data